Abiopharma

Best Dell Monitors for Professional Use in 2025

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-08-04 AccNo: 0002007317-25-000788 Size: 5 KB

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-08-04 AccNo: 0002007317-25-000787 Size: 6 KB

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-08-04 AccNo: 0002007317-25-000786 Size: 5 KB

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-08-04 AccNo: 0002007317-25-000785 Size: 4 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-08-04 AccNo: 0001959173-25-004917 Size: 8 KB

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

New Form 4 - RETRACTABLE TECHNOLOGIES INC Filed: 2025-08-04 AccNo: 0001415889-25-020932 Size: 5 KB

New Form 10-Q - AbbVie Inc. Filed: 2025-08-04 AccNo: 0001551152-25-000040 Size: 11 MB

RXST INVESTOR ALERT: Berger Montague Advises RxSight (NASDAQ: RXST) Investors of a September 22, 2025 Deadline

New Form 3 - Nutex Health, Inc. Filed: 2025-08-04 AccNo: 0001486189-25-000023 Size: 3 KB

Alto Neuroscience, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ANRO

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

FDA approve IRBESARTAN

Biofrontera Notification (BFRI)